Active, not recruitingNCT05446779
Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death
Studying Adrenal Cushing syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Helsinki University Central Hospital
- Principal Investigator
- Niina Matikainen, MD, PhD, Assoc ProfHelsinki University Central Hospital
- Intervention
- Adrenal aldosterone synthase (CYP11B2) staining(diagnostic_test)
- Enrollment
- 400 enrolled
- Eligibility
- 35-70 years · All sexes
- Timeline
- 2022 – 2026
Study locations (1)
- Endocrinology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
Collaborators
Finnish Institute for Health and Welfare · University of Helsinki · Tampere University Hospital · Tampere University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05446779 on ClinicalTrials.govOther trials for Adrenal Cushing syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07168122Establishment and Clinical Application of Reference Intervals of Salivary CortisolShanghai 6th People's Hospital
- RECRUITINGNANCT06250699A Single Center Randomized Controlled Study on the Promotion of Rapid RecoveryZhe Meng
- RECRUITINGNANCT05911620Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous HypercorticismCentral Hospital, Nancy, France
- RECRUITINGNANCT05881005NAC- NAFLD and CushingUniversity Hospital, Angers
- RECRUITINGNCT06050057Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted AdrenalectomyUniversity Hospital Olomouc
- RECRUITINGNCT05521529Cushing's Syndrome Before and After Treatment (CORRECT)University of Aarhus
- RECRUITINGPHASE2NCT03708900Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's SyndromeRECORDATI GROUP
- RECRUITINGPHASE4NCT06801249Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's SyndromeIRCCS Azienda Ospedaliero-Universitaria di Bologna